This decision expands the indication of esketamine, offering new hope for patients with treatment-resistant depression(1 Trusted Source FDA approves new nasalspray medication for treatment ...
NeuroStar is committed to advancing the body of scientific research and elevating mental health treatment through robust research and data-driven innovation,” stated Keith J. Sullivan, President and ...
The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a treatment for depression. A clinic in Denver is looking to help those ...
The following school districts have scheduled closures and delayed starts on Friday, Jan. 31 as a result of storm-related wintry conditions:Westchester CountyBedford Central School District, ...
Results that may be inaccessible to you are currently showing.